Keros Therapeutics, Inc. (KROS) operating margin

Operating margin · fiscal 2025
27.7%

Keros Therapeutics, Inc. (KROS) had an operating margin of 27.7% in fiscal 2025 (the year ended December 31, 2025). That is 5931.8 percentage points higher than the -5904.1% of fiscal 2024. Figures as of 18 Nov 2026, 12:10 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Operating margin, fiscal 2025
27.7%
Change on fiscal 2024
+5931.8 pts
Highest on record
27.7%fiscal 2025
Lowest on record
-110954.3%fiscal 2023
Fiscal years on record
52019–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Figures, not advice.

Keros Therapeutics, Inc. operating margin, in more detail

Across the 5 fiscal years on record (2019–2025), the highest was 27.7% in fiscal 2025 and the lowest -110954.3% in fiscal 2023. The fiscal 2025 figure is higher than in every one of the 4 earlier fiscal years on record, whose median is -3092.3%.

Net margin was 35.7% in fiscal 2025.

History · 5 fiscal years

Operating margin by fiscal year

  • Operating margin
  • Net margin

Keros Therapeutics, Inc. operating margin, year by year

Keros Therapeutics, Inc. (KROS) operating margin by fiscal year
Fiscal yearOperating marginChangeYear endedNet margin
202527.7% 5931.8 pts up35.7%
2024-5904.1% 105050.2 pts up-5277.5%
2023-110954.3%—-101319.2%
2021-280.5%—-292.3%
2019-105.6%—-123.4%

Change is on the fiscal year before, in percentage points; a dash means that year is not on record. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Operating margin is operating income divided by revenue; gross margin does the same with gross profit, and net margin with net income.

How to read it

It shows how much of each unit of sales survives the cost of running the business — rising margins point to pricing power or scale, falling ones to pressure.

More on KROS

Keros Therapeutics, Inc., figure by figure

Keros Therapeutics, Inc. (KROS) overview: price, valuation and scorecard

Keros Therapeutics, Inc. operating margin: questions and answers

What is Keros Therapeutics, Inc.'s operating margin?

Keros Therapeutics, Inc. (KROS) had an operating margin of 27.7% in fiscal 2025 (the year ended December 31, 2025). That is 5931.8 percentage points higher than the -5904.1% of fiscal 2024.

Is Keros Therapeutics, Inc.'s operating margin high or low compared with its own history?

The fiscal 2025 figure is higher than in every one of the 4 earlier fiscal years on record, whose median is -3092.3%.

What are the highest and lowest operating margin figures on record for Keros Therapeutics, Inc.?

Across the 5 fiscal years on record (2019–2025), the highest was 27.7% in fiscal 2025 and the lowest -110954.3% in fiscal 2023.

What are Keros Therapeutics, Inc.'s gross and net margins?

Net margin was 35.7% in fiscal 2025.

How is Keros Therapeutics, Inc.'s operating margin calculated?

Operating margin is operating income divided by revenue; gross margin does the same with gross profit, and net margin with net income. For Keros Therapeutics, Inc. it is on record here for 5 fiscal years, 2019 to 2025.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Keros Therapeutics, Inc. (KROS) operating margin”, data as of 18 November 2026. https://funkfolio.com/stock/KROS/operating-margin

Underlying data: the company's filings with the SEC and Yahoo Finance.